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Abstract: We studied the effects of whey and pumpkin seed oil supplementation on the biochemical parameters in blood 
serum of male rats after chronic ad libitum alcohol consumption. The levels of AST, ALT, total bilirubin, ALP, LDH, 
triglycerides, total cholesterol, HDL, LDL, VLDL, triglyceride/HDL ratio, total cholesterol/HDL ratio (cholesterol ratio) 
and LDL/HDL ratio (index of atherosclerosis) were determined in rats after six weeks of treatment with: (i) ethanol (12% 
ethanol, ad libitum), (ii) whey (2 g/kg per day), (iii) pumpkin seed oil (2 mL/kg per day), (iv) both ethanol and whey, and 
(v) both ethanol and pumpkin seed oil. The results showed no changes in the levels of AST, ALT, total bilirubin, ALP, total 
cholesterol, HDL and VLDL in alcoholic rats when compared to the controls (fed with a standard laboratory diet ad libitum) 
and rats supplemented with whey and pumpkin seed oil. Our results suggest that alcohol consumption in small doses for 
6 weeks changes lipid metabolism and significantly elevates the LDL/HDL ratio (index of atherosclerosis) but does not 
induce extensive liver damage. Ethanol consumption in our experimental conditions lowered the triglyceride level as well 
as the triglyceride/HDL ratio, suggesting lipid redistribution and the induction of some cardio-protective effect. However, 
ethanol induced a higher index of atherosclerosis. Pumpkin seed oil showed some protective potential in alcoholic rats by 
lowering the total cholesterol/HDL ratio, but it elevated the LDH. Whey consumption prevented elevation of the athero-
sclerosis index, pointing to its protective role, probably through the redistribution of lipids. However, whey in combination 
with ethanol elevated LDH.
Key words: whey protein; pumpkin seed oil; ethanol; liver biomarkers; rat
Abbreviations: Alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), body 
weight (b.w.), cholesteryl ester transfer protein (CETP), high density lipoprotein cholesterol (HDL), high density lipopro-
tein particles (HDL-P), lecithin-cholesterol acyltransferase (LCAT), lactate dehydrogenase (LDH), low density lipoprotein 
cholesterol (LDL), low density lipoprotein particles (LDL-P), polyunsaturated fatty acids (PUFA), reactive oxygen species 
(ROS), total cholesterol (TC), triglycerides (TG), very low density lipoprotein cholesterol (VLDL).
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INTRODUCTION
Contemporary lifestyle imposes sedentary behavior 
and increased consumption of alcohol. Ethanol is 
contained in popular drinks and is the most abused 
substance that causes liver injury [1]. Ethanol induces 
hepatotoxicity directly or by its metabolites that in-
volve ROS, acetaldehydes and the release of endotoxin 
from the gastrointestinal tract, inducing the immune 
response and the release of various cytokines and pro-
inflammatory mediators from infiltrating leukocytes 
[2-6]. Ethanol can also induce hepatocyte hypoxia 
and oxidative stress induced by increased oxygen 
consumption during its metabolism [7]. Persistent 
oxidative stress causes fatty liver, which leads to in-
flammation, fibrosis and cirrhosis [8].
The effect of ethanol on the lipid status is known 
and laboratory analyses usually detect the increase 
of triglycerides in the blood. However, research has 
indicated that changes in lipids depend on the amount 
of consumed alcohol as well as on the duration of 
consumption. Alcohol acts on different metabolic 
pathways. Studies on the effect of alcohol on lipid 
metabolism have revealed alterations in gene expres-
sion that lead to the reduction of apoprotein B and 
stimulation of very low density lipoprotein (VLDL) 
cholesterol secretion. Acute alcohol intake can reduce 
the activity of lipoprotein lipase, or lipolysis of circu-
lating chylomicrons and VLDL. In contrast, chronic 
ethanol consumption at low concentrations increases 
the activity of lipoprotein lipase, thus preventing hy-
pertriglyceridemia, although low doses of ethanol are 
insufficient to affect the levels of “bad cholesterol”, 
chylomicrons, low density lipoprotein (LDL) choles-
terol and VLDL [9]. Usually, when the amount of al-
cohol intake is low, but if it is consumed daily, it takes 
time before analyses of blood biochemical parameters 
show any signs of liver toxicity. Therefore, in our ex-
periment we exposed rats to daily intake of a 12% 
ethanol solution ad libitum with no access to water, 
in order to explore how lower doses of alcohol affect 
lipid metabolism and liver function. Moreover, it is 
important to obtain a time threshold for the potential 
treatment of chronic alcoholics.
It has been suggested that ingestion of differ-
ent supplements can prevent liver injury induced by 
chronic alcohol intake. One of them is whey [10], 
which has been suggested as a general liver protective 
mix. Whey is a popular dietetic product for reducing 
body weight and increasing muscle mass during body 
building exercises. It is derived from milk and has 
been studied as a functional food due to its biologi-
cal constituents, such as lactoferrin, β-lactoglobulin, 
α-lactalbumin, glycomacropeptide, immunoglobulins, 
lactose, vitamins and minerals. Whey has the ability to 
act as an antihypertensive, antitumor, hypolipidemic, 
antiviral, antibacterial, and it has a general healing 
factor; its antioxidant properties have been described 
in recent years [11,12].
Pumpkin seed (Cucurbita pepo L.) oil, as a nu-
tritional antioxidant, is a rich source of unsaturated 
fatty acids, antioxidants and fibers, and its antiath-
erogenic and hepatoprotective potential has been 
documented [13]. The high content of unsaturated 
fatty acids (especially linoleic and oleic acids), ca-
rotenoids, γ-aminobutyric acids, sterols, proteins, 
polysaccharides, polyphenols, phytosterols, vitamins 
A and E among other substances, qualifies pumpkin 
seed oil seed as a healthy supplement to human nu-
trition [14]. Previous studies have shown that both 
whey and pumpkin seed oil possess hepatoprotective 
effects [15,16]. Therefore, in the present study we in-
vestigated the effects of whey and pumpkin seed oil 
on serum biochemical parameters that describe body 
fat and liver functionality during chronic low-dose 
alcohol consumption: AST, ALT, total bilirubin, ALP, 
LDH, TG, TC, HDL, LDL, VLDL, and cardiovascular 
risk factors: the TG/HDL, TC/HDL (cholesterol ratio) 
and LDL/HDL (index of atherosclerosis) ratios.
MATERIALS AND METHODS
Ethics Statement
All animals were treated according to directive 
2010/63/EU of the European Parliament on the pro-
tection of animals used for scientific purposes. This 
study was approved by the Ministry of Agriculture 
and Environmental Protection, the Veterinary 
Administration of the Republic of Serbia, Decision no.: 
323-07-10690/2015-05, and by the ethical committee 
of development, regulatory affairs and quality division, 
Galenika a.d., Belgrade, Decision no. 4121/2015.
533Arch Biol Sci. 2018;70(3):531-541 
Animals
The study was conducted on mature male Wistar rats 
aged from 9 to 11 weeks and weighing 200-220 g. The 
animals were housed in standard cages with 3 animals 
per cage, at a constant room temperature (22±1°C) 
and circadian rhythm of 12 h day/night; they were fed 
ad libitum with standard food for laboratory animals 
(produced in the Veterinary Institute, Zemun).
Experimental design
The study included 36 male Wistar rats that were 
divided into 6 groups: (i) control – C (standard ad 
libitum access to food and tap water); (ii) ethanol – E 
(provided with 12% ethanol ad libitum for 42 days 
without any access to water); (iii) whey – W (supple-
mented with 2 g/kg per day during 42 days, standard 
ad libitum access to food and tap water); (iv) pumpkin 
seed oil – P (supplemented with 2 mL/kg per day for 
42 days, standard ad libitum access to food and tap 
water); (v) ethanol and whey E+W (provided with 
12% ethanol ad libitum for 42 days, without access 
to water, supplemented with 2 g/kg per day of whey 
for 42 days, standard ad libitum access to food); (vi) 
ethanol and pumpkin seed oil – E+P (provided with 
12% ethanol ad libitum for 42 days, without access 
to water, 2 mL/kg per day of pumpkin seed oil for 42 
days, standard ad libitum access to food).
The supplements, whey product and commercial 
oil derived from pumpkin seeds, were administered 
with a rat oral gavage tube daily, always at 9 a.m., for 
6 weeks. Supplementation was based on the average 
daily intake of whey and pumpkin seed oil in a diet ex-
trapolated to the daily intake of dry food from humans 
to rats through the “metabolic mass”. The cow whey 
powder contained carbohydrates (61 g/100 g), pro-
teins (11 g/100 g) and lipids (2 g/100 g). Whey powder 
was dissolved in 0.5 g/mL of distilled water. The total 
administered dose was 2 g/kg body weight (b.w.)/day 
for each animal (in 1 mL of the solution). Commercial 
oil derived from pumpkin seeds contained saturated 
fatty acids (19.4 g/100 mL), monounsaturated fatty 
acids (26.2 g/100 mL) and PUFA (46.3 g/100 mL). 
After 6 weeks of treatment, all animals were killed 
by intraperitoneal administration of ketamine (Ket-
amidor 10% 10 mL RighterFaraAG) at a single dose of 
0.224 mg/kg b.w., leading to immediate death. Blood 
samples for biochemical analysis were collected from 
the heart.
Measurement of water and food consumption and 
changes in body weight
Every third day the volume of consumed water and 
the mass of consumed food were measured as the dif-
ference between delivered and remaining water and 
food in the cages. The changes in body weight were 
measured for each animal using a beam scale every 
week during the experiment.
Estimation of biochemical parameters
The serum was separated in the blood samples by cen-
trifugation (3000 x g for 5 min). The concentration 
of ethanol in the blood was measured by gas chro-
matography with the headspace technique GC-FID 
[17]. Analysis of the biochemical parameters (AST, 
ALT, total bilirubin, ALP, LDH, triglycerides, total 
cholesterol, LDL, HDL) were performed on an auto-
mated analyzer (COBAS INTEGRA 400 plus, Roche 
Diagnostic GmbH, Mannheim, Germany), using 
commercial laboratory tests according to the pro-
vided instructions. The concentration of VLDL was 
calculated by subtracting the concentrations of HDL 
and LDL from total cholesterol concentration. Three 
cardiovascular risk factors were calculated: TG/HDL, 
TC/HDL (cholesterol ratio) and LDL/HDL (index of 
atherosclerosis) ratios.
Statistical analysis
Statistical analyses were performed according to 
the protocols described by Hinkle et al. [18]. Val-
ues for liquid and food consumption and b.w. are 
expressed as means. All other values are expressed 
as the mean±SEM. The concentrations of ethanol in 
the blood were compared using one-way ANOVA. 
Changes in b.w. were tested by three-way ANOVA on 
logarithmically transformed data (factors were time, 
i.e. weeks of consumption of ethanol, and supple-
ments) and post hoc compared by Tukey’s HSD test. 
The concentrations of blood biochemical parameters 
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were compared by two-way ANOVA (factors: 
ethanol consumption and supplementation) 
and post hoc compared by Tukey’s HSD test. 
The level of statistical significance for all tests 
was p<0.05.
RESULTS
Liquid consumption
The consumption of liquid was almost uniform 
(90.52 mL/kg b.w./day on average) in all groups 
of animals except in the group treated with 
pumpkin seed oil (P) where the water consump-
tion was higher than in all other groups (106.75 
mL/kg b.w./day) (Fig. 1A).
Concentration of ethanol in the blood
Chronic daily consumption of 12% ethanol ad 
libitum resulted in the presence of ethanol in 
the rats’ blood. There was no difference in the 
ethanol content in the blood of rats that were 
provided ethanol daily with either pumpkin seed 
oil (E+P) (0.372±0.085 g/L) or whey (E+W) 
(0.331±0.060 g/L), and was comparable to the 
ethanol (E) group (0.254±0.070g/L) (Fig. 1B).
Food consumption
The consumption of food was higher in the non-
ethanol groups (C, W, P; 95.47 g/kg b.w./day on 
average) compared to the ethanol groups (E, 
E+W and E+P; 67.82 g/kg b.w./day on average) 
(Fig. 1C).
Weight change of animals during the 
experiment
The highest increase in b.w. was observed in the 
group of animals treated with pumpkin seed oil 
(amounting to 103.77% of the initial b.w.), followed by 
groups treated with ethanol (E) (89.73% of the initial 
b.w.), ethanol and whey (E+W) (80.82% of the initial 
b.w.) and ethanol and pumpkin seed oil (E+P) (76.16% 
of the initial b.w.) (Fig. 1D).
The effect of whey and pumpkin seed oil on blood 
biochemical parameters of alcoholized rats
Six weeks of treatment of rats with ethanol, whey and 
pumpkin seed oil did not lead to significant changes 
in AST, ALT, total bilirubin, ALP, total cholesterol, 
and VLDL levels between the groups (Figs. 2 and 
Fig. 1. Liquid and food consumption, concentration of ethanol in the 
blood and change in body weight during the treatment with whey, pump-
kin seed oil and ethanol. A – Liquid consumption, expressed as the av-
erage consumption per animal during the first three weeks and during 
the second three weeks of the experiment. B – Concentration of ethanol 
in the blood at the end of the experiment. One-way ANOVA showed 
no significant differences between the groups. C – Food consumption, 
expressed as the average consumption per animal during the first three 
weeks and during the second three weeks of the experiment. D – Change 
in b.w. during 6 weeks of the experiment, expressed as the average b.w. for 
each week relative to the initial b.w. Differences between the groups were 
tested by three-way ANOVA (factors: time i.e. weeks (w), consumption 
of ethanol (e) and consumption of supplements (s); p<0.05 was the lower 
limit, and post hoc tested by Tukey’s HSD test. Three-way ANOVA showed 
a significant effect of all three factors: w – there was an increase in the aver-
age b.w. in every week; e – groups treated with ethanol exhibited a smaller 
increase in b.w. when compared to the groups that were not treated with 
the ethanol; s – groups treated with pumpkin seed oil displayed a greater 
increase in b.w. as compared to groups not treated with pumpkin seed 
oil; interaction of w and e – the non-ethanol groups exhibited a greater 
increase during the early phase of the experiment while the ethanolic 
groups exhibited a greater increase of b.w. during the later phase of the 
experiment; interaction of e and s – treatments with whey and pumpkin 
seed oil had the opposite effects on the increase in b.w. in ethanolic and 
non-ethanol groups, namely groups W and P displayed a greater increase 
in b.w. as compared to C, while groups E+W and E+P exhibited a smaller 
increase in b.w. as compared to E. Tukey’s HSD test which showed that the 
group treated with pumpkin seed oil only (P) displayed the greater increase 
in b.w. when compared to all of the other groups. C – control group; W 
– group treated with whey; P – group treated with pumpkin seed oil; E – 
group treated with ethanol; E+W – group treated with ethanol and whey; 
E+P – group treated with ethanol and pumpkin seed oil. *** p<0.001.
535Arch Biol Sci. 2018;70(3):531-541 
showed no significant differences) irrespective of 
the supplementation (Fig. 3). On the other hand, 
consumption of alcohol led to a general increase 
in LDL (two-way ANOVA, ethanol consumption 
effect, F= 4.39, p<0.05; Tukey’s HSD post-hoc 
test showed no significant differences). Two-
way ANOVA also showed that consumption of 
supplements did not have the same effect on the 
concentration of HDL with and without ethanol 
consumption (significant interaction of the two 
factors, F=4.06, p<0.05; Tukey’s HSD post-hoc 
test showed no significant differences).
The TG/HDL ratio was lower in the alcohol-
ized rats (two-way ANOVA, ethanol consumption 
effect, F=5.01, p<0.05; Tukey’s HSD post-hoc test 
showed no significant differences) irrespective of 
the supplementation (Fig. 4). Two-way ANOVA 
also showed that consumption of supplements did 
not have the same effect on the TC/HDL ratio 
with and without ethanol (significant interaction 
of the two factors, F=4.00, p<0.01). Tukey’s HSD 
post-hoc test showed that there was a significant 
decrease (p<0.05) in the TC/HDL ratio in the 
group treated with ethanol and pumpkin seed oil 
(E+P) when compared to the group treated with 
ethanol only (E). The LDL/HDL ratio was higher 
in the alcoholized rats (two-way ANOVA, ethanol 
consumption effect, F=5.60, p<0.05), irrespec-
tive of the supplementation. Two-way ANOVA 
also showed that consumption of supplements did not 
have the same effect on the LDL/HDL ratio in rats with 
and without ethanol (significant interaction of the two 
factors, F=6.40, p<0.01). Tukey’s HSD post-hoc test 
showed that there was a significant increase (p<0.05) 
in the LDL/HDL ratio in the groups treated with etha-
nol (E) and ethanol and pumpkin seed oil (E+P) as 
compared to the control (C).
DISCUSSION
There are no randomized clinical studies that can pro-
vide an answer as to whether the supplementation of 
whey and pumpkin seed oil affects serum biomark-
ers of liver function, but in clinical practice it is of-
ten suggested that whey and herbal supplements can 
induce changes of the biochemical parameters that 
point to their effects on the liver in different diseases 
Fig. 2. Blood indicators of hepatic function: AST, ALT, total bilirubin, 
ALP and LDH after the six-week treatment with whey, pumpkin seed 
oil and ethanol. Differences between the groups were tested by Two-
way ANOVA (factors: consumption of ethanol – e and consumption of 
supplements – s). Only significant ANOVA values are presented (p<0.05 
was the lower limit). When ANOVA showed significant differences, 
Tukey’s HSD post-hoc test was performed to show particular differences. 
Consumption of supplements and ethanol showed no significant effect 
on AST, ALT, total bilirubin and ALP levels. Two-way ANOVA showed 
that consumption of supplements did not have the same effect on the 
LDH level with and without ethanol (significant interaction of e and 
s, p<0.01). Tukey’s HSD post-hoc test showed a significant difference 
between the groups W and P (p<0.05) and groups W and E+W (p<0.05). 
C – control group; W – group treated with whey; P – group treated with 
pumpkin seed oil; E – group treated with ethanol; E+W – group treated 
with ethanol and whey; E+P – group treated with ethanol and pumpkin 
seed oil. * p<0.05.
3). Two-way ANOVA showed that consumption of 
supplements did not have the same effect on the LDH 
level with and without ethanol (significant interaction 
of the two factors, F=6.77, p<0.01) (Fig. 2). Tukey’s 
HSD post-hoc test showed that there was a statisti-
cally significant increase (p<0.05) in LDH levels in the 
group supplemented with pumpkin seed oil (P) when 
compared to the group of animals supplemented with 
whey (W). LDH was also higher in the group supple-
mented with pumpkin seed oil as compared to the 
control group, but at the margin of statistical signifi-
cance. A statistically significant increase (p<0.05) was 
recorded in the group of animals that both consumed 
ethanol and were supplemented with whey (E+W) 
as compared to the group of animals that consumed 
only ethanol (E).
The concentrations of triglycerides were lower in 
alcoholic rats (two-way ANOVA, ethanol consump-
tion effect, F=6.92, p<0.05; Tukey’s HSD post-hoc test 
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[10]. Here we studied the effects of whey and pumpkin 
seed oil supplementation on rats that chronically con-
sumed low ethanol doses ad libitum daily for 6 weeks. 
Our study showed that daily ingestion of the studied 
supplements did not change the level of consump-
tion of ethanol (estimated by the total liquid intake) 
or its concentration in the blood. Ethanol consump-
tion decreased food intake and led to elevated body 
weight. Pumpkin seed oil treatment itself also elevated 
body weight, suggesting that it changed the metabolic 
profile of the rats.
Blood aminotransferase concentrations represent 
an important marker of chronic exposure to ethanol. 
Studies in the human population have shown the in-
crease in plasma aminotransferases and body weight 
after chronic alcohol intake [19-21]. Liangpunsakul et 
al. [21] pointed to the insignificance of tests that de-
termine the levels of aminotransferases if the intake 
of alcohol is less than or about two drinks per 
day. The consumption of alcohol higher than the 
indicated amount leads to an increase in amino-
transferase activities. Our results confirm this. Es-
timation of ethanol intake showed that the daily 
alcohol intake is comparatively low and that AST 
and ALT did not exhibit significant changes after 
6 weeks of consumption. On the other hand, there 
are data that show that acute exposure to alcohol, 
irrespective of the dose, does not lead to signifi-
cant changes in the activity of aminotransferases 
in rats [22]. However, chronic exposure to alco-
hol increases the level of ALT in plasma, without 
changing the level of AST [23]. Previous research 
has shown that 35% alcohol treatment led to an 
increase in aminotransferases [24,25]. However, 
consumption of 12% alcohol ad libitum (0.254 
g/L) during six weeks in our study did not cause 
a significant increase in these biochemical param-
eters, suggesting either that the total consumed 
amount of alcohol or its concentration were low. 
Supplementation with whey and pumpkin seed 
oil did not change the levels of AST and ALT in 
either the alcoholized or control rats.
Furthermore, the total bilirubin levels were 
not changed, suggesting that liver damage did 
not progress. Bilirubin metabolism depends 
on the activity of microsomal UDP-glucuronyl 
transferase, which is important for its conjuga-
tion, as well as the availability of UDP-glucuron-
ic acid and its precursor, UDP-glucose [26]. Studies 
have shown that chronic consumption of ethanol 
leads to an increase in UDP-glucuronyl transferase 
activity [27,28]. The formation of the glucuronide 
conjugate depends on the continuous production of 
UDP-glucuronic acid and can be inhibited by increas-
ing the ratio of NADH/NAD+ during the oxidation 
of ethanol [29]. In our study, total bilirubin was not 
elevated after chronic ethanol consumption and the 
reduction in UDP-glucuronic acid production during 
ethanol oxidation can explain this finding.
The alkaline phosphatase level did not change in 
the different groups of animals. The effects of chron-
ic ethanol consumption on serum and hepatic ALP 
levels have been the subject of controversy [30]. Al-
though most studies showed increased levels of ALP 
[31,32], some researchers did not detect an increase 
Fig. 3. Lipid profile determined after the six-week treatment with whey, 
pumpkin seed oil and ethanol. The levels of: triglycerides, total choles-
terol, HDL, LDL and VLDL are shown. Differences between the groups 
were tested by two-way ANOVA (factors: consumption of ethanol – e 
and consumption of supplements – s). Only significant ANOVA values 
are presented (p<0.05 was the lower limit). When ANOVA showed sig-
nificant differences, Tukey’s HSD post-hoc test was performed to show 
specific differences. Consumption of supplements showed no significant 
effect on the level of any of these lipids/lipoproteins, while consumption 
of ethanol had a significant effect on the level of triglycerides and LDL. 
Ethanol in general decreased the level of TGs (p<0.05) and increased the 
level of LDL (p<0.05). Two-way ANOVA also shows that consumption 
of supplements did not have the same effect on the HDL level with and 
without ethanol (significant interaction of e and s, p<0.05). C – control 
group; W – group treated with whey; P – group treated with pumpkin 
seed oil; E – group treated with ethanol; E+W – group treated with 
ethanol and whey; E+P – group treated with ethanol and pumpkin seed 
oil. * p<0.05.
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in ALP concentration [33]. Our results also suggest 
that the alcohol consumption in our study was insuf-
ficient to change ALP and hence liver metabolism to 
a significant extent.
Pumpkin seed oil intake elevated the concentra-
tion of LDH and suppressed the increase induced 
by ethanol consumption. On the other hand, whey 
supplementation along with alcohol consumption el-
evated LDH levels. This points to the different poten-
tial of these supplements. Elevation of LDH caused by 
pumpkin seed oil suggest caution in its recommenda-
tion, but further parallel consumption of ethanol and 
supplementation with pumpkin seed oil had no effect 
on the already established LDH level. On the other 
hand, supplementation with whey had no effect on 
the LDH level, but parallel consumption of alcohol 
and whey supplementation maintained a healthy liver, 
estimated by the LDH level.
Supplementation of ethanol consumption with 
whey and the intake of pumpkin seed oil alone led 
to a significant increase in LDH. Some authors 
have found that LDH-1, LDH-2 and LDH-3 ac-
tivities were increased in rats treated with a high 
percentage of starch, and it was suggested that 
the disruption of the nutritional status can lead 
to an increase in this enzyme [34]. LDH is an 
enzyme with a role in the conversion of lactate 
to pyruvate. This reaction requires NADH. The 
mechanism by which whey in combination with 
ethanol and pumpkin seed oil alone increases the 
activity of this enzyme could be through a dis-
turbance of the NAD/NADH ratio during their 
metabolism, and a consequent increase in the 
activity of this enzyme. It was found that whey 
protein supplements that precede exercise can 
lead to an elevation of LDH [35].
Total cholesterol levels were not different 
among the groups. Preliminary studies [36] in 
human population have shown that alcohol does 
not lead to an increase in total cholesterol, which 
was also confirmed in our study. Whey and 
pumpkin seed oil supplementation had no ef-
fects on the cholesterol levels. However, ethanol 
consumption decreased triglyceride and the TG/
HDL ratio, sensitive markers of the lipid profile 
used for detecting coronary disease in humans. 
There is a growing number of studies pointing 
to the fact that drinking small amounts of alcohol is 
associated with a fall in triglycerides in the blood [37]. 
These paradoxical effects of the interaction of alcohol 
and triglycerides are brought into conjunction with 
alcohol concentrations and changes in genetic fac-
tors [38].
On the other hand, ethanol elevated LDL levels, 
thus changing the lipid metabolic profile. The index of 
atherosclerosis was also statistically higher in the alco-
holic groups compared to non-alcoholic rats; however, 
whey supplementation suppressed this elevation. This 
suggests a protective effect of whey on atherosclerosis 
development during alcohol ingestion. The TC/HDL 
ratio in the alcoholic groups was lowest in the ethanol 
group supplemented with pumpkin seed oil, which 
can be considered as a protective. Our study showed 
that supplementation with whey and pumpkin seed oil 
modified the lipid metabolic profile in the specific lipid 
metabolic pathway and exerted protection in a differ-
ent way. Moreover, some of the active pumpkin seed 
Fig. 4. Cardiovascular risk factors: TG/HDL ratio, TC/HDL ratio (cho-
lesterol ratio) and LDL/HDL ratio (index of atherosclerosis) after the 
six-week treatment with whey, pumpkin seed oil and ethanol. Differ-
ences between the groups were tested by two-way ANOVA (factors: 
consumption of ethanol – e and consumption of supplements – s). Only 
significant ANOVA values are presented (p<0.05 was the lower limit). 
When ANOVA showed significant differences, Tukey’s HSD post-hoc 
test was performed to show particular differences. Consumption of 
supplements showed no significant effect on any of these three ratios, 
while consumption of ethanol had a significant effect on the TG/HDL 
and LDL/HDL ratios. Ethanol decreased the TG/HDL ratio (p<0.05) and 
increased the LDL/HDL ratio (p<0.05). Two-way ANOVA also showed 
that consumption of supplements did not have the same effect on the 
TC/HDL and LDL/HDL ratios with and without ethanol (significant 
interaction of e and s, p<0.01 for both TC/HDL and LDL/LDH ratios). 
Tukey’s HSD post-hoc test showed a significant difference between the 
groups E and E+P (p<0.05) for TC/HDL ratio and significant difference 
between groups C and E and groups C and E+P (p<0.05 both) for LDL/
HDL ratio. C – control group; W – group treated with whey; P – group 
treated with pumpkin seed oil; E – group treated with ethanol; E+W – 
group treated with ethanol and whey; E+P – group treated with ethanol 
and pumpkin seed oil. * p<0.05.
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oil ingredients, such as antioxidants, can by themselves 
be protective at the metabolic cellular levels. Inges-
tion of ingredients with different PUFA concentrations 
change the lipid profiles attributed to arachidonic acid 
synthesis and thus change the active lipid profile [39-
41]. Studies have shown that the effect of whey at the 
triglyceride level is not expressed in people with a low 
body mass index [10] after intensive exercise [35].
Although studies [42,43] have revealed the cardio-
protective effect of ethanol in the human population 
by increasing HDL cholesterol after chronic alcohol 
consumption, in our research, ethanol did not change 
the HDL cholesterol level. The reason for this result 
may be the decrease in the activity of the lecithin-
cholesterol acyltransferase (LCAT) enzyme due to 
ethanol exposure [44]. The mechanisms by which 
alcohol use could alter lipoprotein distribution can 
be multifactorial. It was found [45,46] that alcohol 
intake is associated with lower cholesteryl ester trans-
fer protein (CETP) activity, but the same results are 
not presented in other studies [47,48]. TaqIB, a vari-
ant of CETP that leads to lower CETP activity, influ-
ences the levels of HDL particles (HDL-P) and LDL 
particles (LDL-P), such as increases in large HDL-P 
and a shift from smaller to larger LDL-P [49]. The 
greatest increase in large HDL-P with alcohol intake 
was reported in a reference study [50], with a smaller 
increase in medium-sized HDL-P. Some investiga-
tors [51] have found that higher levels of small par-
ticle HDL-P are directly associated with higher risk 
of coronary heart disease, in contrast to the effect of 
larger HDL-P [52]. Since previous studies [53] noted 
a decrease in HDL cholesterol level in a diet with high 
amounts of carbohydrates in alcoholics, it seems that 
certain nutritional components of whey and pumpkin 
can be the reason for the absence of change in HDL 
cholesterol levels [54]. A meta-analysis study [10] 
showed that whey supplementation did not change 
the HDL-cholesterol level.
The levels of VLDL cholesterol in our experiment 
did not exhibit changes between the examined groups 
of animals. A study in humans [50] showed that dur-
ing ethanol exposure, the levels of VLDL cholesterol 
change in a stepwise manner depending on the amount 
of consumed alcoholic beverages. In this study, in-
creased consumption of alcohol tends to decrease the 
levels of VLDL cholesterol that can be a consequence 
of the alcohol-induced stimulation of lipoprotein li-
pase [55]. This suggests that ethanol consumption in 
our experiment was low, as in other studies. Studies 
have shown an increase in LDL cholesterol in chronic 
alcohol consumption [56]. Our results revealed that 
chronic consumption of alcohol elevated LDL levels. 
Supplementation with whey and pumpkin seed oil did 
not prevent LDL level elevation, but whey had a pro-
tective impact on the atherosclerosis index.
Consumption of ethanol leads to an increase in 
the availability of fatty acids in the liver, and therefore 
there is an increased likelihood of their storage in the 
liver, as well as increased release through lipoprotein. 
The endoplasmic reticulum is a site where lipid es-
terification and lipoprotein production take place. It 
is possible that the ethanol-induced proliferation of 
the smooth endoplasmic reticulum plays an important 
role in increasing the capacity of the liver to produce 
lipoproteins [57,58]. Studies [59,60] have shown that 
the combinations of certain food supplements and 
ethanol lead to the development of alcoholic liver 
disease. This is demonstrated by the combination 
of ethanol and corn oil rich in linoleic acid [59]. It 
was also reported that increased intake of PUFA in 
combination with alcohol promotes oxidative stress. 
However, our results have shown that pumpkin seed 
oil with alcohol changes lipid metabolism, but the 
reason for the increase in this class of lipoproteins 
is alcohol consumption. Pumpkin seed oil together 
with ethanol lowered the TC/HDL ratio, suggesting a 
protective effect that was obtained by subtle changes 
in lipid metabolism.
Taken together, our results showed that chronic 
daily consumption of alcohol produced changes in 
the liver lipid metabolic profile that led to decreased 
TG and increased the level of LDL and atherogenic 
risk. However, changes in biochemical parameters do 
not reveal significant liver damage, but LDH levels 
provide evidence that subtle pathohistological changes 
occurred in the liver, which were expressed in changed 
biochemical parameters. Furthermore, supplementa-
tion with pumpkin seed oil changed metabolism itself, 
suggesting that concomitant use of different supple-
ments has to take into consideration the individual 
metabolic pathways. Supplementation with whey 
along the consumption of alcohol increased LDH 
levels and provided a protective effect on the athero-
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sclerosis index. However, additional histopathological 
and biochemical aspects need to be investigated in 
order to provide a clearer picture of the prophylactic 
properties of whey and pumpkin seed oil supplemen-
tation on chronic ethanol damage.
CONCLUSIONS
Our study shows that daily consumption of whey and 
pumpkin seed oil had no effect on the ethanol-me-
diated increase in LDL and decrease in triglycerides. 
However, the supplements had some protective effects 
on the lipid status, the atherosclerosis index and on 
general health risk factors. Pumpkin seed oil intake 
itself changed the lipid metabolic profile of treated 
rats. However, pumpkin seed oil and whey with etha-
nol led to an elevation in LDH, suggesting potentially 
harmful effects.
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